Zymeworks
ZYME
109 hedge funds and large institutions have $1.2B invested in Zymeworks in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 35 increasing their positions, 46 reducing their positions, and 23 closing their positions.
31% more call options, than puts
Call options by funds: $7.05M | Put options by funds: $5.38M
8% more capital invested
Capital invested by funds: $1.12B → $1.2B (+$84M)
1.47% less ownership
Funds ownership: 76.26% → 74.79% (-1.5%)
13% less funds holding
Funds holding: 125 → 109 (-16)
24% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 46
70% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 23
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$57.2M |
| 2 |
BlackRock
New York
|
+$18.6M |
| 3 |
Morgan Stanley
New York
|
+$18.2M |
| 4 |
AC
Armistice Capital
New York
|
+$11.1M |
| 5 |
Holocene Advisors
New York
|
+$10.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$40.6M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$21.5M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$18.9M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$15.2M |
| 5 |
SAM
Scion Asset Management
Saratoga,
California
|
-$8.88M |
ZYME Hedge Fund Activity: Q2 2021 in Review
109 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q2 2021, worth a combined $1.2B — up 7.5% from $1.12B a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of ZYME and 7 opened new positions — a net loss of 16 holders — while 46 trimmed existing stakes and 35 added.
The largest buyer was Eventide Asset Management, adding an estimated $57.2M. The largest seller was Fidelity Investments, cutting an estimated $40.6M.
- 109 institutional investors held Zymeworks (ZYME) as of Q2 2021, down from 125 in Q1 2021.
- Funds reported $1.2B of Zymeworks stock for Q2 2021, up 7.5% quarter-over-quarter.
- 7 funds opened new Zymeworks positions in Q2 2021 and 23 closed out, a net change of -16 holders.
- The largest Zymeworks buyer in Q2 2021 was Eventide Asset Management, an estimated $57.2M added.
- The largest Zymeworks seller in Q2 2021 was Fidelity Investments, an estimated $40.6M sold.
Based on aggregated 13F filings for Q2 2021.